Aggressive Light Chain Amyloidosis Cases have Unstable Immunoglobulin Light Chains

2004 ◽  
pp. 55-57
Author(s):  
L. A. Sikkink ◽  
E. M. Baden ◽  
S. R. Vance ◽  
K. J.-L. Riley ◽  
A.T. Moch ◽  
...  
2016 ◽  
Vol 292 (6) ◽  
pp. 2328-2344 ◽  
Author(s):  
Kathrin Andrich ◽  
Ute Hegenbart ◽  
Christoph Kimmich ◽  
Niraja Kedia ◽  
H. Robert Bergen ◽  
...  

2004 ◽  
pp. 55-57
Author(s):  
K J.-L. Riley ◽  
M Ramirez-Alvarado ◽  
E Baden ◽  
S Vance ◽  
L Sikkink ◽  
...  

1998 ◽  
Vol 153 (1) ◽  
pp. 313-318 ◽  
Author(s):  
Catherine Decourt ◽  
Guy Touchard ◽  
Jean-Louis Preud'homme ◽  
Ruben Vidal ◽  
Hélène Beaufils ◽  
...  

2019 ◽  
Vol 116 (17) ◽  
pp. 8360-8369 ◽  
Author(s):  
Gareth J. Morgan ◽  
Nicholas L. Yan ◽  
David E. Mortenson ◽  
Enrico Rennella ◽  
Joshua M. Blundon ◽  
...  

In Ig light-chain (LC) amyloidosis (AL), the unique antibody LC protein that is secreted by monoclonal plasma cells in each patient misfolds and/or aggregates, a process leading to organ degeneration. As a step toward developing treatments for AL patients with substantial cardiac involvement who have difficulty tolerating existing chemotherapy regimens, we introduce small-molecule kinetic stabilizers of the native dimeric structure of full-length LCs, which can slow or stop the amyloidogenicity cascade at its origin. A protease-coupled fluorescence polarization-based high-throughput screen was employed to identify small molecules that kinetically stabilize LCs. NMR and X-ray crystallographic data demonstrate that at least one structural family of hits bind at the LC–LC dimerization interface within full-length LCs, utilizing variable-domain residues that are highly conserved in most AL patients. Stopping the amyloidogenesis cascade at the beginning is a proven strategy to ameliorate postmitotic tissue degeneration.


1997 ◽  
Vol 272 (3) ◽  
pp. F319-F324 ◽  
Author(s):  
L. Zhu ◽  
G. A. Herrera ◽  
C. R. White ◽  
P. W. Sanders

This study examined the hypothesis that certain immunoglobulin light chains directly altered mesangial cell calcium homeostasis. Intracellular Ca2+ concentration (intracellular [Ca2+]) signaling was determined in suspensions of rat mesangial cells using the acetoxymethyl ester of fura 2 with a calcium removal/replacement protocol. Pretreatment of cultured rat mesangial cells with a glomerulopathic kappa-light chain (gle) produced reversible dose- and time-dependent attenuation of ATP- and thrombin-evoked [Ca2+] transients (189 +/- 24 vs. 126 +/- 10 nM, P < 0.05 with ATP; 198 +/- 5 vs. 117 +/- 3 nM, P < 0.05 with thrombin) and capacitative calcium influx (199 +/- 14 vs. 142 +/- 17 nM, P < 0.05 for ATP; 252 +/- 19 vs. 198 +/- 18 nM, P < 0.05 for thrombin). Mesangial cells treated with gle and supplemented with myo-inositol (450 microM) did not demonstrate the attenuation of the ATP-evoked [Ca2+] transient and capacitative calcium influx. Gle also decreased mean [Ca2+] transient (80 +/- 7 vs. 56 +/- 1 nM, P < 0.05) and capacitative calcium influx (306 +/- 10 vs. 241 +/- 4 nM, P < 0.05) in response to thapsigargin, a Ca2+-adenosinetriphosphatase inhibitor. This inhibition was not reversed by exogenous myo-inositol. Another kappa-light chain (10 microg/ml) did not affect mesangial cell calcium signaling. Deranged mesangial cell calcium homeostasis by certain light chains may play a central pathogenetic role in glomerulosclerosis associated with deposition of immunoglobulin light chains.


1979 ◽  
Vol 25 (8) ◽  
pp. 1495-1498 ◽  
Author(s):  
J Cejka ◽  
K Kithier

Abstract Serum from a patient with multiple myeloma showed a monoclonal protein, classified by immunoelectrophoresis as IgD. Immunofixation electrophoresis and immunoelectrophoresis failed to demonstrate a precipitation reaction between the paraprotein and antisera to immunoglobulin light chains. The light chains of the monoclonal protein, immunologically inaccessible in the intact molecule, reacted with anti-lambda chain antisera only after reduction and alkylation of the paraprotein. Moreover, interpretation of the immunoelectrophoretic patterns was hampered by the presence in patient's serum of free lambda chains having about the same mobility as that of the paraprotein.


Leukemia ◽  
2017 ◽  
Vol 32 (3) ◽  
pp. 729-735 ◽  
Author(s):  
S Sidana ◽  
N Tandon ◽  
A Dispenzieri ◽  
M A Gertz ◽  
F K Buadi ◽  
...  

2020 ◽  
Vol 13 (6) ◽  
pp. e234361
Author(s):  
Rebaika Chopra ◽  
Rosalba Santana de Roberts ◽  
Ibrahim Batal ◽  
Sachin Batra ◽  
Belinda Jim

Kidney tubular disorders due to monoclonal immunoglobulin light chains are common manifestations of B-cell neoplasm. Cast nephropathy (CN) is the most frequent type of these disorders and may present with acute kidney injury (AKI) due to the presence of excess light chains in the distal tubules. Light chain proximal tubulopathy (LCPT) is an uncommon form of renal disease and may present as Fanconi syndrome due to proximal tubular cell damage by intracellular deposition of light chains. The concomitant disorder of both CN and LCPT is rare given the inherent differences in the biochemical properties of the immunoglobulin light chains of each disorder. We report a 64-year-old man who presented with AKI and Fanconi syndrome who was discovered to have both CN and LCPT due to the underlying disorder of monoclonal gammopathy of renal significance and who has responded favourably with conventional chemotherapy. We also review the existing literature on this interesting subject.


1992 ◽  
Vol 38 (4) ◽  
pp. 548-550 ◽  
Author(s):  
K R Herkner ◽  
H Salzer ◽  
A Böck ◽  
A Mühl ◽  
T Tsaka ◽  
...  

Abstract In routine analysis for immunoglobulin light chains in pediatric diagnostics, the age-related reference intervals for serum kappa (kappa) and lambda (lambda) light chains were evaluated in 1543 healthy subjects (newborns to age 16 years, including 168 premature infants). Light-chain analysis was performed by rate nephelometry. IgG, IgA, and IgM were measured simultaneously, and heavy- and light-chain differences were calculated for control purposes. Results for IgG, IgA, and IgM generally agreed with reference intervals reported in the literature. kappa showed age-related changes comparable with changes in IgG concentrations, whereas lambda showed moderate fluctuations. The kappa/lambda ratio showed an almost linear increase with age, starting with 0.97 at four months and reaching the highest value of 2.21 at 15 years (mean values). Preterm infants presented with markedly low serum concentrations of IgG and corresponding light chains but with adult-type kappa/lambda ratios because of the maternal-origin IgG.


Sign in / Sign up

Export Citation Format

Share Document